Posted by Michael Wonder on 10 Mar 2023
Will NZ neurological drug Trofinetide for Rett syndrome get US FDA approval and make history?
10 March 2023 - Kiwi scientists may be about to make New Zealand history, with a breakthrough treatment on the cusp of becoming our first drug of its kind to make it to market.
Within days, Distinguished Professor Dame Margaret Brimble and fellow researchers expect to hear whether the drug they developed is granted final marketing approval by the US FDA.
